Search results
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
WHTC 1450 Holland· 17 hours agoBy Michael Erman (Reuters) - Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 1 day agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoWhich of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by YCharts The case for Novavax Novavax earned approval...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 1 day agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 1 day agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 3 days ago“We don’t yet know if the manufacturers will have patient assistance programs.” Vaccine...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 3 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...